Formation of p27-CDK complexes during the human mitotic cell cycle

Cell Growth and Differentiation

Volumn 7, Issue 2, 1996, Pages 135-146

  Soos, Timothy J ^a   Kiyokawa, Hiroaki ^a   Yan, Jie Shi ^a   Rubin, Mark Stephen ^a   Giordano, Antonio ^b   DeBlasio, Anthony ^a   Bottega, Steve ^a   Wong, Birming ^a   Mendelson, John ^a   Koff, Andrew ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; ONCOPROTEIN;

ARTICLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; GROWTH REGULATION; HUMAN; HUMAN CELL; MITOSIS RATE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CDC2-CDC28 KINASES; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CRICETINAE; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; G1 PHASE; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MITOSIS; MOLECULAR WEIGHT; PROTEIN-SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 9044232147     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Sherr, C. J Mammalian G1 cyclins. Cell, 73: 1059-1065, 1993.
2. Ohtsubo, M., and Roberts, J. M. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science (Washington DC), 259: 1908-1912, 1993.
3. Quell, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J. Y., Bar-Sagi, D., Roussel, M. F., and Sherr, C. J. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes & Dev., 7: 1559-1571, 1993.
4. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol., 14: 1669-1679, 1994.
5. 1-to-S transition. Mol. Cell. Biol., 15: 3463-3469, 1995.
6. Sherr, C. J., and Roberts, J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes & Dev., 9: 1149-1163, 1995.
7. Peter, M., and Herskowitz, I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell, 79: 181-184, 1994.
8. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
9. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
10. INK4B is a potential effector of TGFβ-induced cell cycle arrest. Nature (Lond.), 371: 257-261, 1994.
11. Guan, K. L., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C. L., Matera, A. G., and Xiong, Y. Growth suppression by p18, a p16INK4/ MTS1- and p14INK4B/MTS2-related CDK6 inhibitor: correlates with wild-type pRb function. Genes & Dev., 8: 2939-2952, 1994.
12. El-Deiry, W. S., Tokino, T., Vellculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
13. Gu, Y., Turck, C. W., and Morgan, D. O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature (Lond.), 366: 707-710, 1993.
14. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K , and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
15. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
16. Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., and Smith, J. R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211: 90-98, 1994.
17. Hengst. L., Dulic, V., Slingerland, J M., Lees, E., and Reed, S. I. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA. 91: 5291-5295, 1994.
18. KIP1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes & Dev., 8: 9-22, 1994.
19. KIP1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular anti-mitogenic signals. Cell, 78: 59-66, 1994.
20. Toyoshima, H., and Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78: 67-74, 1994.
21. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes & Dev., 9: 639-649, 1995.
22. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes & Dev , 9: 650-662, 1995.
23. Reynisdottir, I., Polyak, K., Iavarone, A., and Massagué, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes & Dev., 9: 1831-1845, 1995.
24. Jiang, H., Lin, J., Su, Z. Z., Collart, F. R., Hubermann, E., and Fisher, P. B. Induction of differentiation in human promyelocytic HL-60 Leukemia cells activates p21. WAF1/CIP1: expression in the absence of p53. Oncogene, 9: 3397-3406, 1994.
25. Steinman, R. A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D. A., and El-Houseini, M. E. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene, 9: 3389-3396, 1994.
26. WAF1/CDK2 complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition. J. Cell. Biol., 131: 235-242, 1995.
27. Koff, A., Ohtsuki, M., Polyak, K., Roberts, J. M., and Massagué, J. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by JGF-β. Science (Washington DC), 260: 536-539, 1993.
28. Slingerland, J. M., Hengst, L., Pan, C. H., Alexander, D., Stampfer, M. R., and Reed, S. I. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol. Cell. Biol., 14: 3683-3694, 1994.
29. KIP1) of cyclin-dependent kinase 4 activation. Cell, 79: 487-496, 1994.
30. Nakanishi, M., Robetoyre, R. S., Adami, G. R., Pereira-Smith, O. M., and Smith, J. R. Identification of the active region of the DNA synthesis inhibitory gene P21Sdi1/CIP1/WAF1. EMBO J., 14: 555-563, 1995
31. Zhang, H., Hannon, G. J., and Beach, D p21-containing cyclin kinases exist in both active and inactive states. Genes & Dev., 8: 1750-1758, 1994.
32. KIP1, an inhibitor of cyclin-dependent kinases. Prog. Cell Cycle Res., 1. 141-147, 1995.
33. INK4. Cancer Res., 54: 5816-5820, 1994.
34. INK4/MTS1 tumor suppressor gene product. EMBO J., 14: 503-511.
35. Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L-H., Zhang, P., Dobrowolski, S., Bai, C , Connell-Crowley, L., Swindell, E., Fox, M. P., and Wei, N. Inhibition of cyclin-dependent kinases by p21. Mol Biol. Cell, 6: 387-400, 1995
36. Poon, R. Y. C., Toyoshima, H., and Hunter, T. Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell, 6: 1197-1213, 1995.
37. Marraccino, R. L., Firpo, E. J., and Roberts, J. M. Activation of the p34 CDC2 protein kinase at the start of S-phase in the human cell cycle. Mol. Biol. Cell., 3: 389-401, 1992.
38. Grana, X., DeLuca, A., Sang, N., Fu, Y., Claudio, P. P., Rosenblatt, J., Morgan, D. O., and Giordano, A. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc. Natl. Acad. Sci. USA, 91: 3834-3838, 1994.
39. 1 phase of the cell cycle. Cell, 65: 701-713, 1991.
40. Knoblich, J. A., Sauer, K., Jones, L., Richardson, H., Saint, R., and Lehner, C. F. Cyclin E controls S phase progression and its down-regulation during Drosophilia embryogenesis is required for the arrest of cell proliferation. Cell, 77: 107-120, 1994.
41. 1-to-S phase transition Mol. Cell. Biol., 15: 2612-2624, 1995.
42. 1 phase of the human cell cycle. Science (Washington DC), 257: 1689-1694, 1992.
43. Dulic, V., Lees, E., and Reed, S. I. Human cyclin E is associated with a periodic G1 protein kinase. Science (Washington DC), 257: 1958-1961, 1992.
44. Firpo, E. J., Koff, A., Solomon, M. J., and Roberts, J. M. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T-lymphocytes. Mol. Cell. Biol., 14: 4889-4901, 1994.
45. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (Lond.), 372: 570-573, 1994.
46. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
47. Pines, J. Cyclins, CDKs, and cancer. Semin. Cancer Biol., 6: 63-72, 1995.
48. Koff, A., Cross, F., Fisher, A., Schumacher, J., Leguellec, K., Philippe, M., and Roberts, J. M. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell, 66: 1217-1228, 1991.
49. Gudagno, T. M., Ohtsubo, M., Roberts, J. M., and Assoian, R. K A link between cyclin A expression and adhesion-dependent cell cycle progression. Science (Washington DC), 262: 1572-1575, 1993.
50. Kiyokawa, H., Richon, V. M., Rifkind, R. A., and Marks, P. A. Suppression of cyclin-dependent kinase 4 during induced differentiation of erytholeukemia cells. Mol. Cell. Biol., 14: 7195-7203, 1994.